Limitations of Continuous Glucose Monitor Usage
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Much progress has been made in diabetes treatments since the first dose of insulin was administered in 1921. However, a truly transformational moment in diabetes care occurred when urine testing gave way to capillary blood home glucose monitoring. As improvements were made to these devices, continuous glucose monitoring (CGM) was introduced. The advantages of experiential learnings gleaned from seeing continuous real-time data have been borne out in numerous peer-reviewed journals. Limitations to use of CGM include patient's level of numeracy and literacy, development of alarm fatigue, interfering substances leading to erroneous readings, high rates of discontinuation, and poor reimbursement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring
Cengiz, E., & Tamborlane, W. V. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0002 · Cited by 390 · cited 1×
“Ascorbic acid and salicylate ingestion, and other causes of in vivo measurement error include lag time between capillary blood glucose and the interstitial space, trauma at the site insertion, changes in perfusion at the sensor site, and physical pressure placed on the sensor.(20) Accuracy and discomfort are major cau…”
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318 · cited 1×
“Not surprisingly they also found that patients could maximize their benefit by wearing the devices more frequently and using them in real time.(21) No discussion about limitations to usage of diabetes devices is complete without addressing the lack of adoption due to poor reimbursement.”
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Continuous glucose monitoring systems for type 1 diabetes mellitus
Langendam, M., Luijf, Y. M., Hooft, L., DeVries, J. H., Mudde, A. H., & Scholten, R. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008101.pub2 · Cited by 262
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., White, N. H., Weinzimer, S. A., Tamborlane, W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1746 · Cited by 204
Cited by
Lawton, J., Blackburn, M., Allen, J., Campbell, F., Elleri, D., Leelarathna, L., Rankin, D., Tauschmann, M., Thabit, H., & Hovorka, R. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0239-1 · Cited by 174
“using CGM for a limited number of weeks and it is possible that participants might have experienced fatigue had they used CGM for longer due to frustrations arising from alarms and CGM systems prompting action as soon as blood glucose moves out of predefined ranges [33, 34].”
MethodVoormolen, D. N., DeVries, J. H., Sanson, R. M. E., Heringa, M. P., de Valk, H. W., Kok, M., van Loon, A. J., Hoogenberg, K., Bekedam, D. J., Brouwer, T. C. B., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13310 · Cited by 151
Koeneman, M., Olde Bekkink, M., Meijel, L. V., Bredie, S., & de Galan, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211007485 · Cited by 11
Metadata
- Authors
- Anhalt, H.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2016-03
- Volume
- 18
- Issue
- 3
- Pages
- 115-117
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2299876101
- Cited by
- 39
- References
- 9
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.